1H-MR spectroscopy indicates severity markers in temporal lobe epilepsy: Correlations between metabolic alterations, seizures, and epileptic discharges in EEG

Epilepsia

Volumn 48, Issue 2, 2007, Pages 263-269

  Hammen, Thilo ^a   Schwarz, Michael ^a   Doelken, Marc ^a   Kerling, Frank ^a   Engelhorn, Tobias ^a   Stadlbauer, Andreas ^a   Ganslandt, Oliver ^a   Nimsky, Christopher ^a   Doerfler, Arnd ^a   Stefan, Hermann ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

1H MR Spectroscopy; Epileptic discharges in EEG; Metabolic alterations; Seizures; Temporal lobe epilepsy

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FEMALE; GLIOSIS; HIPPOCAMPUS; HUMAN; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE; SYMPTOM; TEMPORAL LOBE EPILEPSY; BRAIN MAPPING; COMPARATIVE STUDY; ELECTROENCEPHALOGRAPHY; HEMISPHERIC DOMINANCE; HOSPITALIZATION; METABOLISM; MONITORING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; STATISTICS; TEMPORAL LOBE; VIDEORECORDING;

ASPARTIC ACID; BIOLOGICAL MARKER; CHOLINE; CREATINE; DIPEPTIDE; DRUG DERIVATIVE; GLUTAMINE; N ACETYL 1 ASPARTYLGLUTAMIC ACID; N ACETYLASPARTIC ACID; N-ACETYL-1-ASPARTYLGLUTAMIC ACID; N-ACETYLASPARTATE; UNCLASSIFIED DRUG;

ADULT; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN MAPPING; CHOLINE; CREATINE; DIPEPTIDES; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; FEMALE; FUNCTIONAL LATERALITY; GLUTAMINE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MONITORING, PHYSIOLOGIC; SEIZURES; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE; VIDEOTAPE RECORDING;

EID: 33846826971     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00856.x     Document Type: Article

References (32)

1. Achten E, Boon P, Van De Kerckhove T, Caemaer TJ, De Reuck J, Kunnen M. (1997) Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy. AJNR American Journal of Neuroradiology 18:1131-1139.
2. 1H-NMR spectroscopic studies of brain. Neuroscience Biobehavior Review 13:23-31.
3. Block W, Traber F, Flacke S, Jessen F, Pohl C, Schild H. (2002) In-vivo proton MR-spectroscopy of the human brain: assessment of N- acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 23:317-323.
4. Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. (1997) Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Annals of Neurology 42:737-746.
5. Chiappa KH, Hill RA, Huang-Hellinge RF, Jenkins BG. (1999) Photosensitive epilepsy studied by functional magnetic resonance imaging and magnetic resonance spectroscopy. Epilepsia 40(suppl 4):3-7.
6. Connelly A, Jackson GD, Duncan JS, King MD. Gadian DG. (1994) Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 44:1411-1417.
7. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, Bloch G, Hantraye P. (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. Journal of Cerebral Blood Flow and Metabolism 20:789-799.
8. 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magnetic Resonance Imaging 16:969-979.
9. Gadian DG. (1995) N-acetylaspartate and epilepsy. Magnetic Resonance Imaging 13:1193-1195.
10. 1H magnetic resonance spectroscopic imaging. Magnetic Resonance Imaging 15:475-478.
11. 1H MR spectroscopy in patients with mesial temporal epilepsy. Magma 7:95-114.
12. 1HMR spectroscopy: a promising method in distinguishing subgroups in temporal lobe epilepsy? Journal of Neurological Science 215:21-25.
13. Helms G. (2000) A precise and user-independent quantification technique for regional comparison of single volume proton MR spectroscopy of the human brain. NMR in Biomedicine 13:398-406.
14. Kamada K, Takeuchi F, Houkin K, Kitagawa M, Kuriki S, Ogata A, Tashiro K, Koyanagi I, Mitsumori K, Kiwasaki Y. (2001) Reversible brain dysfunction in MELAS: MEG, and (1)H MRS analysis. Journal of Neurology, Neurosurgery and Psychiatry 70:675-678.
15. 31P spectroscopy of an interictal cortical spike focus in the rat. Epilepsia 32:446-453.
16. Kuzniecky R. (1998) Symptomatic occipital lobe epilepsy. Epilepsia 39(suppl 4):S24-S31.
17. Kuzniecky R, Suggs S, Gaudier J, Faught E. (1991) Lateralization of epileptic foci by magnetic resonance imaging in temporal lobe epilepsy. Journal of Neuroimaging 1:163-167.
18. LM, Cendes F, Andermann F, Dubeau F, Arnold DL. (2000a) Spatial extent of neuronal metabolic dysfunction measured by proton MR spectroscopic imaging in patients with localization-related epilepsy. Epilepsia 41:666-674.
19. LM, Cendes F, Antel SB, Andermann F, Serles W, Dubeau F, Olivier A, Arnold DL. (2000b) Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Annals of Neurology 47:195-200.
20. Lin DD, Crawford TO, Barker PB. (2003) Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR American Journal of Neuroradiology 24:33-4.
21. Margerison JH, Corsellis JA. (1966) Epilepsy and the temporal lobes: a clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 89:499-530.
22. 1H magnetic resonance spectroscopic imaging. Neurology 43:509-515.
23. 1H-MRS- detected metabolic abnormalities in mesial temporal lobe epilepsy. Epilepsia 43:1385-1389.
24. Provencher SW. (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance Medicine 30:672-679.
25. 1H spectra with LC Model. NMR in Biomedicine 14:260-264.
26. 1H-MRSI-measured NAA/Cr. Epilepsia 40:1821-1827.
27. Shih JJ, Weisend MP, Lewine J, Sanders J, Dermon J, Lee R. (2004) Areas of interictal spiking are associated with metabolic dysfunction in MRI-negative temporal lobe epilepsy. Epilepsia 45:223-229.
28. Stefan H, Wang Y, Pauli E, Schmidt B. (2004) A new approach in antiepileptic drug evaluation. European Journal of Neurology 11:467-473.
29. Urenjak J, Williams SR, Gadian DG, Noble M. (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. Journal of Neurochemistry 59:55-61.
30. Urenjak J, Williams SR, Gadian DG, Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience 13:981-989.
31. Vermathen P, Ende G, Laxer KD, Knowlton RC, Matson GB, Weiner MW. (1997) Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Annals of Neurology 42:194-199.
32. 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Annals of Neurology 45:369-376.